CARULLI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 12.182
EU - Europa 5.892
AS - Asia 5.326
SA - Sud America 607
AF - Africa 70
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 24.097
Nazione #
US - Stati Uniti d'America 12.084
CN - Cina 1.871
GB - Regno Unito 1.810
SG - Singapore 1.762
IT - Italia 1.587
HK - Hong Kong 722
DE - Germania 612
SE - Svezia 562
BR - Brasile 486
UA - Ucraina 325
TR - Turchia 305
RU - Federazione Russa 231
FI - Finlandia 217
VN - Vietnam 210
FR - Francia 177
KR - Corea 158
BG - Bulgaria 122
IN - India 64
AR - Argentina 57
CA - Canada 44
NL - Olanda 42
MX - Messico 39
JP - Giappone 35
BD - Bangladesh 33
IE - Irlanda 33
ID - Indonesia 32
CH - Svizzera 28
PL - Polonia 26
ZA - Sudafrica 26
CZ - Repubblica Ceca 22
ES - Italia 20
BE - Belgio 19
TW - Taiwan 19
EC - Ecuador 18
IQ - Iraq 18
AE - Emirati Arabi Uniti 15
MY - Malesia 14
AT - Austria 12
PT - Portogallo 10
CL - Cile 9
IR - Iran 9
MA - Marocco 9
UZ - Uzbekistan 9
CO - Colombia 8
EU - Europa 8
PY - Paraguay 8
VE - Venezuela 8
LT - Lituania 7
PE - Perù 7
RO - Romania 7
AU - Australia 6
EG - Egitto 6
IL - Israele 6
KE - Kenya 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
PH - Filippine 5
SI - Slovenia 5
BO - Bolivia 4
DZ - Algeria 4
GE - Georgia 4
JO - Giordania 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
SA - Arabia Saudita 4
UG - Uganda 4
BH - Bahrain 3
HR - Croazia 3
HU - Ungheria 3
KZ - Kazakistan 3
PA - Panama 3
BY - Bielorussia 2
CR - Costa Rica 2
GH - Ghana 2
GR - Grecia 2
KW - Kuwait 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
DK - Danimarca 1
GA - Gabon 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
Totale 24.092
Città #
Santa Clara 1.213
Singapore 1.175
Southend 1.147
Fairfield 1.029
Ashburn 795
Woodbridge 789
Jacksonville 724
Chandler 721
Hong Kong 718
Hefei 689
Houston 614
Dearborn 492
Ann Arbor 469
Wilmington 373
Seattle 372
Cambridge 359
Chicago 351
Nyköping 346
London 299
Beijing 290
Los Angeles 268
Izmir 182
Seoul 148
Salt Lake City 136
New York 130
Princeton 127
Modena 123
San Diego 123
Sofia 120
Eugene 115
Milan 112
Des Moines 110
The Dalles 104
Munich 103
Shanghai 93
Rome 87
Tampa 83
Grafing 73
Ho Chi Minh City 72
Helsinki 71
Elk Grove Village 70
Buffalo 68
Moscow 68
Dallas 60
São Paulo 53
Council Bluffs 52
Columbus 49
Bremen 48
Falls Church 46
Bologna 44
Hanoi 43
Sterling 36
Boardman 31
Dublin 30
Guangzhou 30
Turku 30
Kunming 29
Lancaster 27
Napoli 27
Turin 27
Bari 26
Naples 26
Kent 25
Redwood City 25
Tokyo 22
Torino 22
Warsaw 22
Brooklyn 20
Miami 20
Brno 19
Jakarta 19
San Mateo 19
Phoenix 18
Brussels 17
Frankfurt am Main 17
Verona 17
Nanjing 16
Palermo 16
Catania 15
Florence 15
Mexico City 15
Parma 15
Sondrio 15
Zhengzhou 15
Atlanta 14
Fremont 14
Norwalk 14
Toronto 14
Amsterdam 13
Rio de Janeiro 13
San Francisco 13
Stockholm 13
Baghdad 12
Chennai 12
Dulles 12
Hounslow 12
Kilburn 12
Detroit 11
Dongguan 11
Ninh Bình 11
Totale 16.870
Nome #
Le basi scientifiche dell'approccio bio-psico-sociale. Indicazioni per l'acquisizione delle competenze mediche appropriate 1.481
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 407
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 373
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 370
Review article: diabetes, genetics and ethnicity 347
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 345
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 343
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 324
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 318
Characteristics of patients in a ward of Academic Internal Medicine. Implications for medical care, training programs and research 309
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 305
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 302
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 293
Growth of human herpesvirus 6 in HepG2 cells 289
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 284
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 284
Factors associated with gallstone disease in the MICOL experience 277
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 264
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 264
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 255
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 252
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 249
Advances in the comprehension of the pathophysiology of bile secretion 248
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 248
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 247
Chicken or egg turned into head or belly 245
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 239
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 234
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 227
Growth hormone plasma levels in nonalcoholic fatty liver disease 224
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 224
Effects of acute changes of bile acid pool composition on biliary lipid secretion 223
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 223
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 221
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 221
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 218
Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) 217
Bile acid structure and regulation of biliary protein secretion and composition in man 216
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 215
Review article: hyperlipidaemia and cardiovascular risk 212
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 208
Influence of age and sex on serum concentrations of total dimeric activin A 208
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 208
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 207
BILE CHANGES DURING TREATMENT WITH DEOXYCHOLIC-ACID - REPLY 206
Effect of ursocholic acid on bile lipid secretion and composition 206
In vivo evaluation of cholesterol 7 alpha-hydroxylation in humans: effect of disease and drug treatment 200
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 200
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 200
Fecal neutral steroids in normal conditions and in patients with polyps or cancer of the large bowel 197
Statins and HCV: a complex issue 195
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 193
Bile acid and hepatocyte death 190
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 190
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 190
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 189
Regolazione della sintesi di colesterolo e acidi biliari 181
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 181
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 179
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease 179
Reply 176
HCV and diabetes. A two-question-based reappraisal. 173
Dysmetabolic changes associated with HCV: a distinct syndrome? 173
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 171
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 171
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 167
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 165
Cirrosi criptogenetiche. Un report di 5 pazienti 164
Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7alpha-hydroxylation in humans 163
Chronic hepatopathies: from cryptogenetics to multiple factors 161
Patogenesi della colelitiasi 160
Effect of acute administration of bile acids on fatty acid composition of biliary phosphatidylcholine in man 160
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 157
Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. 157
EFFECT OF FISH OIL AND COCONUT OIL DIET ON THE LDL RECEPTOR ACTIVITY OF RAT LIVER PLASMA MEMBRANES. 156
Colelitiasi sintomatica: affiorano dubbi sulla necessita' dell'intervento. 155
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 155
Prevalence rates of gallstone disease in Italy: the Chianciano population study 154
Complications following percutaneous liver biopsy: a multicenter retrospective study on 68.276 biopsies 154
Hepatitis C and steatosis: a reappraisal 151
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 151
Ursodeoxycholic acid improves liver tests in chronic hepatitis - Results of a randomised controlled trial 150
Nuove prospettive terapeutiche con acidi biliari. 150
Cholestatic icterus: is there still a role for the clinic? 150
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 149
Fatty liver, carotid disease and gallstones: A study ofage-related associations 147
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 145
Risk for cardiovascular events in a local population of diabetic patients 145
Should nonalcoholic fatty liver disease be renamed? 145
Patogenesi ed epidemiologia della steatosi epatica e della steatoepatite non alcolica (NASH). 144
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 143
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 143
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 143
Acute abdomen associated with schistosomiasis of the appendix 143
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 142
Dietary cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size. 142
Gallstone dissolution. 139
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 135
regulation of bile acid synthesis in humans: availability of newly sythetized cholesterol is a limiting fator during pharmacological inhibition of bile acid recirculation. 133
DIABETES AND CARDIOVASCULAR EVENTS: USEFULNESS AND LIMITS OF RISK FUNCTIONS 132
Totale 22.058
Categoria #
all - tutte 95.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.173 0 0 0 0 0 89 215 285 91 246 156 91
2021/20222.156 70 273 194 200 54 114 155 118 229 125 365 259
2022/20232.135 235 218 135 210 241 379 59 185 270 31 89 83
2023/20241.387 72 68 66 108 267 131 182 178 45 49 84 137
2024/20254.750 181 92 104 315 988 599 381 219 442 176 550 703
2025/20265.139 514 441 706 1.119 2.023 336 0 0 0 0 0 0
Totale 24.166